Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT (2017)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.1182/bloodadvances.2017008094
- Subjects: CÉLULAS-TRONCO; COMORBIDADE; MORTALIDADE
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Título: Blood Advances
- ISSN: 2473-9537
- Volume/Número/Paginação/Ano: v. 1, n. 8, p. 1409-1413, 2017
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
XHAARD, Aliénor et al. Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT. Blood Advances, v. 1, n. 8, p. 1409-1413, 2017Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017008094. Acesso em: 14 mar. 2026. -
APA
Xhaard, A., Cunha, R., Busson, M., Robin, M., Dhedin, N., Coman, T., et al. (2017). Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT. Blood Advances, 1( 8), 1409-1413. doi:10.1182/bloodadvances.2017008094 -
NLM
Xhaard A, Cunha R, Busson M, Robin M, Dhedin N, Coman T, Cabannes-Hamy A, Fontbrune FS de, Michonneau D, Socié G, Calado R do T, Latour RP de. Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT [Internet]. Blood Advances. 2017 ; 1( 8): 1409-1413.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1182/bloodadvances.2017008094 -
Vancouver
Xhaard A, Cunha R, Busson M, Robin M, Dhedin N, Coman T, Cabannes-Hamy A, Fontbrune FS de, Michonneau D, Socié G, Calado R do T, Latour RP de. Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT [Internet]. Blood Advances. 2017 ; 1( 8): 1409-1413.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1182/bloodadvances.2017008094 - Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs
- Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: overlapping pathophysiology with therapeutic implications
- Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia
- Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia
- Telomere shortening in hepatocyte proliferation and predisposition to alcohol-induced steatosis
- Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress
- Telomere dynamics in iPS cells derived from human patients with telomerase mutations
- Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
- A mutation in the CCAAT box of the TERC promoter region causes telomere disease
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
